|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of BioRestorative Therapies (NASDAQ: BRTX) through any online brokerage.
The latest price target for BioRestorative Therapies (NASDAQ: BRTX) was reported by Roth Capital on December 1, 2021. The analyst firm set a price target for 37.00 expecting BRTX to rise to within 12 months (a possible 590.30% upside). 1 analyst firms have reported ratings in the last year.
The stock price for BioRestorative Therapies (NASDAQ: BRTX) is $5.36 last updated Tue Dec 07 2021 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for BioRestorative Therapies.
BioRestorative Therapies’s $Q4 earnings are confirmed for after-market on February 19, 2022.
There is no upcoming split for BioRestorative Therapies.
BioRestorative Therapies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.